BB-101

BIOLOGICAL2 trials

Sponsors

Blue Blood Biotech Corp.

Conditions

Diabetic Foot Ulcer

Phase 1

BB-101 for Treatment of Diabetic Lower Leg and Foot Ulcers

CompletedNCT03888053

Blue Blood Biotech Corp.Diabetic Foot Ulcer

Start: 2018-03-28End: 2023-12-31Updated: 2026-04-22

Phase 2

BB-101 for the Treatment of Diabetic Lower Leg and Foot Ulcers

RecruitingNCT06383013

Blue Blood Biotech Corp.Diabetic Foot Ulcer

Start: 2024-05-01End: 2028-12-31Target: 96Updated: 2026-04-22